- Home
- MLP vs ITOS Comparison
MLP vs ITOS Comparison
Compare MLP & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLP
- ITOS
- Stock Information
- Founded
- MLP 1909
- ITOS 2011
- Country
- MLP United States
- ITOS United States
- Employees
- MLP N/A
- ITOS N/A
- Industry
- MLP Real Estate
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MLP Finance
- ITOS Health Care
- Exchange
- MLP Nasdaq
- ITOS Nasdaq
- Market Cap
- MLP 344.7M
- ITOS 381.2M
- IPO Year
- MLP 1972
- ITOS 2020
- Fundamental
- Price
- MLP $17.37
- ITOS $10.26
- Analyst Decision
- MLP
- ITOS Hold
- Analyst Count
- MLP 0
- ITOS 6
- Target Price
- MLP N/A
- ITOS $10.60
- AVG Volume (30 Days)
- MLP 22.6K
- ITOS 764.9K
- Earning Date
- MLP 08-18-2025
- ITOS 08-07-2025
- Dividend Yield
- MLP N/A
- ITOS N/A
- EPS Growth
- MLP N/A
- ITOS N/A
- EPS
- MLP N/A
- ITOS N/A
- Revenue
- MLP $14,886,000.00
- ITOS $35,000,000.00
- Revenue This Year
- MLP N/A
- ITOS N/A
- Revenue Next Year
- MLP N/A
- ITOS N/A
- P/E Ratio
- MLP N/A
- ITOS N/A
- Revenue Growth
- MLP 57.13
- ITOS 177.89
- 52 Week Low
- MLP $14.05
- ITOS $4.80
- 52 Week High
- MLP $26.46
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- MLP 48.98
- ITOS 66.97
- Support Level
- MLP $17.72
- ITOS $10.05
- Resistance Level
- MLP $18.58
- ITOS $10.21
- Average True Range (ATR)
- MLP 0.77
- ITOS 0.13
- MACD
- MLP -0.08
- ITOS -0.06
- Stochastic Oscillator
- MLP 35.80
- ITOS 81.48
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.